Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 7/20 | 0.46 |
| ▸ | RARG | P13631 | 5/20 | 0.46 |
| ▸ | PDE5A | O76074 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MPO | P05164 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5604905 | 0.85 | GAA (0.43) | RORCRARGKDM4EL3MBTL1GAA | |
| SCHEMBL27512371 | 0.83 | RORC (0.43) | RORCRARGPDE5AGAASCN9A | |
| SCHEMBL4084107 | 0.78 | TRPA1 (0.36) | RORC | |
| SCHEMBL3161095 | 0.76 | PDE5A (0.48) | RORCRARGPDE5AKDM4EATM | |
| SCHEMBL2677079 | 0.76 | PDE5A (0.44) | RORCRARGPDE5AKDM4EATM | |
| SCHEMBL10831975 | 0.76 | MAPT (0.47) | RORCRARGPDE5AKDM4EATM | |
| SCHEMBL10315082 | 0.76 | MAPK1 (0.62) | GAAMAPK1HTTKMT2ACYP19A1 | |
| SCHEMBL11963485 | 0.76 | CNR1 (0.40) | — | |
| SCHEMBL5487133 | 0.74 | PDE5A (0.54) | PDE5AKDM4EGAANPSR1ALDH1A1 | |
| SCHEMBL29342349 | 0.73 | CNR1 (0.59) | PDE5AKDM4EALDH1A1MAPK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080036373-A1 | Platinum complex and light-emitting device | TAKASAGO INTERNATIONAL CORPORATION | 2008-02-14 | — | — | US | disclosed |
| US-20080036373-A1 | Platinum complex and light-emitting device | TAKASAGO INTERNATIONAL CORPORATION | 2008-02-14 | — | — | US | disclosed |
| US-20080036373-A1 | Platinum complex and light-emitting device | TAKASAGO INTERNATIONAL CORPORATION | 2008-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080036373-A1 | Platinum complex and light-emitting device | XPA, ERCC4, UACA | RORC 657/4885RARG 800/4885PDE5A 4259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.